Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basmisanil in Dup15q Syndrome
NCT05307679Phase 2Terminated
- Sponsor
- Roche
- Start
- Dec 2022
- Primary completion
- Mar 2024
- Countries
- 3
01
Overview
A Phase 2 trial of basmisanil in dup15q syndrome, sponsored by Roche. Started Dec 2022; status: terminated.
02
Drugs
basmisanil
03
Conditions
dup15q syndrome
Beyond the preview
Go deeper on NCT05307679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05307679.